| Monkeypox virus infection in humans across 16 countries—April–June 2022 JP Thornhill, S Barkati, S Walmsley, J Rockstroh, A Antinori, LB Harrison, ... New England Journal of Medicine 387 (8), 679-691, 2022 | 1738 | 2022 |
| COVID-19: Exposing and addressing health disparities among ethnic minorities and migrants C Greenaway, S Hargreaves, S Barkati, CM Coyle, F Gobbi, A Veizis, ... Journal of travel medicine 27 (7), taaa113, 2020 | 245 | 2020 |
| Two-dose SARS-CoV-2 vaccine effectiveness with mixed schedules and extended dosing intervals: test-negative design studies from British Columbia and Quebec, Canada DM Skowronski, S Setayeshgar, Y Febriani, M Ouakki, M Zou, D Talbot, ... MedRxiv, 2021.10. 26.21265397, 2021 | 121 | 2021 |
| Epidemiological and clinical characteristics of patients with monkeypox in the GeoSentinel Network: a cross-sectional study KM Angelo, T Smith, D Camprubí-Ferrer, L Balerdi-Sarasola, ... The Lancet Infectious Diseases 23 (2), 196-206, 2023 | 119 | 2023 |
| Protection against omicron (B. 1.1. 529) BA. 2 reinfection conferred by primary omicron BA. 1 or pre-omicron SARS-CoV-2 infection among health-care workers with and without … S Carazo, DM Skowronski, M Brisson, S Barkati, C Sauvageau, ... The Lancet Infectious Diseases 23 (1), 45-55, 2023 | 98 | 2023 |
| Shigella spp. with reduced azithromycin susceptibility, Quebec, Canada, 2012–2013 C Gaudreau, S Barkati, JM Leduc, PA Pilon, J Favreau, S Bekal Emerging infectious diseases 20 (5), 854, 2014 | 59 | 2014 |
| SHARE-net clinical group JP Thornhill, S Barkati, S Walmsley, J Rockstroh, A Antinori, LB Harrison, ... Monkeypox virus infection in humans across 16, 679-91, 2022 | 54 | 2022 |
| Two-dose severe acute respiratory syndrome coronavirus 2 vaccine effectiveness with mixed schedules and extended dosing intervals: test-negative design studies from British … DM Skowronski, Y Febriani, M Ouakki, S Setayeshgar, S El Adam, M Zou, ... Clinical Infectious Diseases 75 (11), 1980-1992, 2022 | 51 | 2022 |
| Estimated protection of prior SARS-CoV-2 infection against reinfection with the Omicron variant among messenger RNA–vaccinated and nonvaccinated individuals in Quebec, Canada S Carazo, DM Skowronski, M Brisson, C Sauvageau, N Brousseau, ... JAMA network open 5 (10), e2236670-e2236670, 2022 | 49 | 2022 |
| Practices of Lyme disease diagnosis and treatment by general practitioners in Quebec, 2008–2015 S Gasmi, NH Ogden, PA Leighton, A Adam-Poupart, F Milord, LR Lindsay, ... BMC family practice 18, 1-8, 2017 | 33 | 2017 |
| Cutaneous leishmaniasis in the 21st century: from the laboratory to the bedside S Barkati, M Ndao, M Libman Current Opinion in Infectious Diseases 32 (5), 419-425, 2019 | 28 | 2019 |
| Protection against Omicron re-infection conferred by prior heterologous SARS-CoV-2 infection, with and without mRNA vaccination S Carazo, DM Skowronski, M Brisson, C Sauvageau, N Brousseau, ... medRxiv, 2022.04. 29.22274455, 2022 | 25 | 2022 |
| Outcomes of hospitalized COVID-19 patients in Canada: impact of ethnicity, migration status and country of birth AM Passos-Castilho, AC Labbé, S Barkati, ML Luong, O Dagher, ... Journal of Travel Medicine 29 (6), taac041, 2022 | 21 | 2022 |
| Single-dose mRNA vaccine effectiveness against SARS-CoV-2 in healthcare workers extending 16 weeks post-vaccination: a test-negative design from Quebec, Canada S Carazo, D Talbot, N Boulianne, M Brisson, R Gilca, G Deceuninck, ... medRxiv, 2021.07. 19.21260445, 2021 | 21 | 2021 |
| Monkeypox in Montréal: epidemiology, phylogenomics, and public health response to a large North American outbreak LB Harrison, G Bergeron, G Cadieux, H Charest, J Fafard, I Levade, ... Annals of Internal Medicine 176 (1), 67-76, 2023 | 19 | 2023 |
| Incidence of invasive aspergillosis following remission–induction chemotherapy for acute leukemia: a retrospective cohort study in a single Canadian tertiary care centre S Barkati, SF Dufresne, S Bélanger, B Vadnais, J Bergeron, AC Labbé, ... Canadian Medical Association Open Access Journal 2 (2), E86-E93, 2014 | 17 | 2014 |
| Single-dose messenger RNA vaccine effectiveness against severe acute respiratory syndrome coronavirus 2 in healthcare workers extending 16 weeks postvaccination: a test … S Carazo, D Talbot, N Boulianne, M Brisson, R Gilca, G Deceuninck, ... Clinical Infectious Diseases 75 (1), e805-e813, 2022 | 13 | 2022 |
| Strongyloidiasis in immunocompromised migrants to non-endemic countries in the era of COVID-19: what is the role for presumptive ivermectin? S Barkati, C Greenaway, MD Libman Journal of Travel Medicine 29 (1), taab155, 2022 | 11 | 2022 |
| First Human Case of Metacestode Infection Caused by Versteria sp. in a Kidney Transplant Recipient S Barkati, B Gottstein, N Müller, C Sheitoyan-Pesant, P Metrakos, ... Clinical Infectious Diseases 68 (4), 680-683, 2019 | 11 | 2019 |
| Dengue outbreak amongst travellers returning from Cuba—GeoSentinel surveillance network, January–September 2022 M Díaz-Menéndez, KM Angelo, R de Miguel Buckley, E Bottieau, R Huits, ... Journal of travel medicine 30 (2), taac139, 2023 | 10 | 2023 |
